Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionbeta-catenin binding

APC SALL1 KDM6B KLF4

1.28e-04120434GO:0008013
GeneOntologyMolecularFunctionkinase binding

APC IRS1 CEP192 ULK1 PER2 MICAL2 PDPK1 SPRED3 MAP3K2

1.82e-04969439GO:0019900
GeneOntologyMolecularFunctionprotein kinase binding

APC IRS1 CEP192 ULK1 MICAL2 PDPK1 SPRED3 MAP3K2

4.80e-04873438GO:0019901
GeneOntologyMolecularFunctionphosphatidylinositol 3-kinase regulator activity

IRS1 KLF4

6.78e-0418432GO:0035014
GeneOntologyMolecularFunctionchromatin binding

CAMTA2 NKX6-1 SALL1 KDM6B KLF4 NFE2L1 WAC

9.32e-04739437GO:0003682
GeneOntologyBiologicalProcessepithelial cell differentiation

APC HEG1 NKX6-1 SALL1 KDM6B UBN1 KLF4 ZFP36L1 NFE2L1 PDPK1 SPRED3

1.51e-068704411GO:0030855
GeneOntologyBiologicalProcessregulation of epithelial cell differentiation

APC NKX6-1 SALL1 ZFP36L1 NFE2L1 SPRED3

6.40e-06217446GO:0030856
GeneOntologyBiologicalProcessepithelium development

APC HEG1 NKX6-1 SALL1 KDM6B UBN1 KLF4 ZFP36L1 NFE2L1 MICAL2 PDPK1 SPRED3

4.03e-0514694412GO:0060429
GeneOntologyBiologicalProcesspositive regulation of peptidyl-lysine acetylation

DIP2B DIP2A

9.28e-057442GO:2000758
GeneOntologyBiologicalProcessnegative regulation of mitotic cell cycle phase transition

APC CEP192 KLF4 ZFP36L1 WAC

9.99e-05219445GO:1901991
GeneOntologyBiologicalProcessnegative regulation of cell cycle process

APC TNKS CEP192 KLF4 ZFP36L1 WAC

1.13e-04362446GO:0010948
DomainDMAP_binding

DIP2B DIP2A

5.15e-055432PF06464
DomainDMAP_binding

DIP2B DIP2A

7.72e-056432SM01137
DomainDMAP1-bd

DIP2B DIP2A

7.72e-056432IPR010506
DomainSEA

MUC16 MUC12

1.16e-0322432PF01390
DomainSEA

MUC16 MUC12

1.27e-0323432PS50024
DomainSEA_dom

MUC16 MUC12

1.27e-0323432IPR000082
DomainAMP-binding

DIP2B DIP2A

2.16e-0330432PF00501
DomainAMP-dep_Synth/Lig

DIP2B DIP2A

2.16e-0330432IPR000873
DomainANK_REPEAT

ANKRD11 MUC16 TNKS CAMTA2

2.68e-03253434PS50088
DomainANK_REP_REGION

ANKRD11 MUC16 TNKS CAMTA2

2.72e-03254434PS50297
DomainEGF_1

HEG1 MUC12 NRXN3 MUC4

2.76e-03255434PS00022
DomainEGF-like_CS

HEG1 MUC12 NRXN3 MUC4

3.00e-03261434IPR013032
DomainEGF

HEG1 NRXN3 MUC4

3.04e-03126433PF00008
DomainEGF_2

HEG1 MUC12 NRXN3 MUC4

3.17e-03265434PS01186
PathwayREACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC

MUC16 MUC12 MUC4

4.78e-0616303M27410
PathwayREACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS

MUC16 MUC12 MUC4

5.80e-0617303M27412
PathwayWP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING

DOCK3 APC IRS1 PDPK1 MAP3K2

1.20e-05144305M39691
PathwayREACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS

MUC16 MUC12 MUC4

1.50e-0523303M556
PathwayREACTOME_DECTIN_2_FAMILY

MUC16 MUC12 MUC4

2.19e-0526303M27483
PathwayWP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY

APC IRS1 SALL1 KDM6B KLF4 ARID3B

3.47e-05301306MM15983
PathwayREACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS

MUC16 MUC12 MUC4 PDPK1

2.09e-04140304M27484
PathwayREACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS

MUC16 MUC12 MUC4

3.02e-0462303M546
PathwayREACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS

MUC16 MUC12 MUC4

3.97e-0468303M27303
PathwayPID_MTOR_4PATHWAY

IRS1 ULK1 PDPK1

4.14e-0469303M121
PathwayWP_LEPTININSULIN_SIGNALING_OVERLAP

IRS1 PDPK1

5.84e-0417302M39517
PathwayWP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS

APC TNKS

5.84e-0417302M39525
PathwayWP_LEPTININSULIN_SIGNALING_OVERLAP

IRS1 PDPK1

8.12e-0420302MM15867
PathwayBIOCARTA_GSK3_PATHWAY

APC PDPK1

8.12e-0420302M11106
PathwayWP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA

APC KLF4 ROR1

8.73e-0489303M39563
PathwayREACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS

MUC16 MUC4

8.97e-0421302MM15706
PathwayBIOCARTA_GSK3_PATHWAY

APC PDPK1

9.85e-0422302MM1421
PathwayBIOCARTA_EIF4_PATHWAY

IRS1 PDPK1

1.08e-0323302MM1470
PathwayBIOCARTA_EIF4_PATHWAY

IRS1 PDPK1

1.17e-0324302M4791
PathwaySIG_IL4RECEPTOR_IN_B_LYPHOCYTES

IRS1 PDPK1

1.49e-0327302M1718
PathwayWP_GASTRIC_CANCER_NETWORK_1

APC CEP192

1.60e-0328302M39347
PathwayREACTOME_O_LINKED_GLYCOSYLATION

MUC16 MUC12 MUC4

1.65e-03111303M27416
PathwayPID_IGF1_PATHWAY

IRS1 PDPK1

1.72e-0329302M125
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS

SALL1 KLF4

1.96e-0331302M27393
Pubmed

Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.

MCAM MUC16 MUC12 MUC4

6.73e-091844418834073
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

ANKRD11 DOCK3 DIP2A IRS1 CEP192 HEG1 ULK1 KDM6B UBN1 PER2 KLF4

9.29e-081105441135748872
Pubmed

HectD1 E3 ligase modifies adenomatous polyposis coli (APC) with polyubiquitin to promote the APC-axin interaction.

APC TNKS CTTNBP2NL

5.36e-071344323277359
Pubmed

JMJD3 acts in tandem with KLF4 to facilitate reprogramming to pluripotency.

KDM6B KLF4

1.56e-06244233033262
Pubmed

Expression of the gut-enriched Krüppel-like factor gene during development and intestinal tumorigenesis.

APC KLF4

1.56e-0624429428642
Pubmed

Period 2 mutation accelerates ApcMin/+ tumorigenesis.

APC PER2

1.56e-06244219010825
Pubmed

Depletion of transmembrane mucin 4 (Muc4) alters intestinal homeostasis in a genetically engineered mouse model of colorectal cancer.

APC MUC4

1.56e-06244235255004
Pubmed

Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II.

IRS1 PDPK1

1.56e-06244215802620
Pubmed

Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.

MUC16 MUC4

1.56e-06244223544943
Pubmed

Decreased expression of the gut-enriched Krüppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients.

APC KLF4

1.56e-06244210913614
Pubmed

KLF4 Suppresses Tumor Formation in Genetic and Pharmacological Mouse Models of Colonic Tumorigenesis.

APC KLF4

1.56e-06244226839262
Pubmed

Olig2 targets chromatin remodelers to enhancers to initiate oligodendrocyte differentiation.

APC SALL1 KDM6B

1.80e-061944323332759
Pubmed

Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.

MUC16 MUC4

4.69e-06344223053434
Pubmed

HEG1 Protects Against Atherosclerosis by Regulating Stable Flow-Induced KLF2/4 Expression in Endothelial Cells.

HEG1 KLF4

4.69e-06344238099436
Pubmed

BET protein-dependent E2F pathway activity confers bell-shaped type resistance to tankyrase inhibitors in APC-mutated colorectal cancer.

APC TNKS

4.69e-06344238216082
Pubmed

Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.

MUC16 MUC4

4.69e-06344230236127
Pubmed

Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone.

MUC16 MUC4

4.69e-06344217592322
Pubmed

Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.

MUC16 MUC12

4.69e-06344226770020
Pubmed

CGG-repeat expansion in the DIP2B gene is associated with the fragile site FRA12A on chromosome 12q13.1.

DIP2B DIP2A

4.69e-06344217236128
Pubmed

Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis.

APC KLF4

4.69e-06344217671182
Pubmed

Serine 389 phosphorylation of 3-phosphoinositide-dependent kinase 1 by UNC-51-like kinase 1 affects its ability to regulate Akt and p70 S6kinase.

ULK1 PDPK1

4.69e-06344232317083
Pubmed

TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression.

APC IRS1

4.69e-06344230679431
Pubmed

Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection.

MUC16 MUC4

4.69e-06344235879412
Pubmed

Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).

MUC16 MUC4

4.69e-06344227483328
Pubmed

MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer.

MUC16 MUC4

4.69e-06344224204560
Pubmed

Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.

MUC16 MUC4

4.69e-06344224939955
Pubmed

KLF4 interacts with beta-catenin/TCF4 and blocks p300/CBP recruitment by beta-catenin.

APC KLF4

9.37e-06444219901072
Pubmed

Insulin receptor substrate-1 deficiency promotes apoptosis in the putative intestinal crypt stem cell region, limits Apcmin/+ tumors, and regulates Sox9.

APC IRS1

9.37e-06444217916629
Pubmed

Tankyrases maintain homeostasis of intestinal epithelium by preventing cell death.

APC TNKS

9.37e-06444230260955
Pubmed

Biologically anchored knowledge expansion approach uncovers KLF4 as a novel insulin signaling regulator.

IRS1 KLF4

9.37e-06444230240435
Pubmed

TRPV4 activation in human corneal epithelial cells promotes membrane mucin production.

MUC16 MUC4

9.37e-06444239024979
Pubmed

Hyperglycemia induces vascular smooth muscle cell dedifferentiation by suppressing insulin receptor substrate-1-mediated p53/KLF4 complex stabilization.

IRS1 KLF4

9.37e-06444230578299
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

ANKRD11 APC DIP2B IRS1 CEP192 ZFP36L1 MAP3K2 CCSER1

1.10e-0586144836931259
Pubmed

MRTFB suppresses colorectal cancer development through regulating SPDL1 and MCAM.

MCAM APC

1.56e-05544231690663
Pubmed

Beta-catenin induces beta-TrCP-mediated PER2 degradation altering circadian clock gene expression in intestinal mucosa of ApcMin/+ mice.

APC PER2

1.56e-05544219106159
Pubmed

Targeting PDK1 with dichloroacetophenone to inhibit acute myeloid leukemia (AML) cell growth.

ULK1 PDPK1

1.56e-05544226593251
Pubmed

LEF1 and B9L shield β-catenin from inactivation by Axin, desensitizing colorectal cancer cells to tankyrase inhibitors.

APC TNKS

1.56e-05544224419084
Pubmed

Brf1 loss and not overexpression disrupts tissues homeostasis in the intestine, liver and pancreas.

APC ZFP36L1

2.34e-05644230858608
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

DOCK3 APC DIP2A NCKAP5 TNKS KDM6B HERPUD2 MICAL2 WAC

2.75e-05128544935914814
Pubmed

Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.

APC MTMR1 DIP2B TNKS ZNF385B SPRED3

2.86e-0547544631040226
Pubmed

Loss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female mice.

APC KLF4

3.27e-05744224204315
Pubmed

Modeling of a human circadian mutation yields insights into clock regulation by PER2.

APC PER2

3.27e-05744217218255
Pubmed

Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B.

IRS1 PDPK1

4.36e-05844212167717
Pubmed

ADP-ribosylation factor-like GTPase 15 enhances insulin-induced AKT phosphorylation in the IR/IRS1/AKT pathway by interacting with ASAP2 and regulating PDPK1 activity.

IRS1 PDPK1

4.36e-05844228322786
Pubmed

Genome-wide association study of bipolar disorder in European American and African American individuals.

NCKAP5 ROR1

4.36e-05844219488044
Pubmed

Sall1 maintains nephron progenitors and nascent nephrons by acting as both an activator and a repressor.

NKX6-1 SALL1

5.60e-05944224744442
Pubmed

Statistical analysis of the 5' untranslated region of human mRNA using "Oligo-Capped" cDNA libraries.

MCAM COL17A1

6.99e-051044210756096
Pubmed

The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.

MCAM MTMR1 DIP2B COL17A1 MICAL2 ROR1

7.78e-0556944630639242
Pubmed

Single-Cell Transcriptomics Uncovers Glial Progenitor Diversity and Cell Fate Determinants during Development and Gliomagenesis.

APC ZFP36L1

8.54e-051144230982771
Pubmed

FLCN, a novel autophagy component, interacts with GABARAP and is regulated by ULK1 phosphorylation.

FNIP2 ULK1

1.41e-041444225126726
Pubmed

Genome-wide siRNA screen reveals amino acid starvation-induced autophagy requires SCOC and WAC.

ULK1 WAC

1.41e-041444222354037
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

FNIP2 CAMTA2 CEP192 ULK1 PER2

1.60e-0440744512693553
Pubmed

Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.

SALL1 UBN1 BAZ2B ARID3B

1.80e-0422244437071664
Pubmed

A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.

SERTAD4 MUC16 MTMR1 DIP2A ROR1

1.85e-0442044528065597
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

DOCK3 TNKS SALL1 UBN1 NFE2L1

2.06e-0443044535044719
Pubmed

The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.

ANKRD11 TNKS

2.10e-041744223502783
Pubmed

An expanded Oct4 interaction network: implications for stem cell biology, development, and disease.

SALL1 KLF4 ARID3B

2.12e-049144320362542
Pubmed

A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.

APC MTMR1 PER2 NFE2L1

2.12e-0423244425515538
Pubmed

The contribution of de novo coding mutations to autism spectrum disorder.

DIP2A KDM6B

2.36e-041844225363768
Pubmed

Identification of proximal SUMO-dependent interactors using SUMO-ID.

MCAM SALL1 UBN1 CTTNBP2NL ARID3B

2.39e-0444444534795231
Pubmed

HEY1 functions are regulated by its phosphorylation at Ser-68.

APC TNKS CEP192

2.41e-049544327129302
Pubmed

Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

ULK1 NRXN3 MICAL2

2.89e-041014439872452
Pubmed

Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.

APC IRS1 MAP3K2

2.97e-0410244315778465
Pubmed

Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

FNIP2 DIP2B BAZ2B

3.06e-0410344310819331
Pubmed

Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

DOCK3 KDM6B PER2

3.15e-041044439205841
Pubmed

Major β cell-specific functions of NKX2.2 are mediated via the NK2-specific domain.

APC NKX6-1

3.56e-042244237364986
Pubmed

Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection.

APC NKX6-1

3.56e-042244211955448
Pubmed

WNT10A mutation causes ectodermal dysplasia by impairing progenitor cell proliferation and KLF4-mediated differentiation.

COL17A1 KLF4

4.24e-042444228589954
Pubmed

Rheb1 is required for mTORC1 and myelination in postnatal brain development.

APC IRS1

4.61e-042544221238928
Pubmed

Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways.

APC IRS1

4.61e-042544218992263
Pubmed

HENA, heterogeneous network-based data set for Alzheimer's disease.

APC TNKS CCSER1

4.78e-0412044331413325
Pubmed

The tumor suppressor PTEN and the PDK1 kinase regulate formation of the columnar neural epithelium.

NKX6-1 PDPK1

4.99e-042644226809587
Pubmed

Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin.

DIP2B DIP2A

5.79e-042844231600191
Pubmed

Floor plate-derived sonic hedgehog regulates glial and ependymal cell fates in the developing spinal cord.

APC NKX6-1

6.65e-043044223482494
Pubmed

The utility and predictive value of combinations of low penetrance genes for screening and risk prediction of colorectal cancer.

APC IRS1

7.57e-043244220437058
Pubmed

Onset of Spinal Cord Astrocyte Precursor Emigration from the Ventricular Zone Involves the Zeb1 Transcription Factor.

APC NKX6-1

7.57e-043244227806288
Pubmed

Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon.

KLF4 MUC4

8.06e-043344216618389
Pubmed

The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.

ANKRD11 UBN1 NFE2L1 SEC14L5

8.19e-0433244437433992
Pubmed

CITGeneDB: a comprehensive database of human and mouse genes enhancing or suppressing cold-induced thermogenesis validated by perturbation experiments in mice.

APC KDM6B PER2

8.46e-0414644329688375
Pubmed

APC haploinsufficiency coupled with p53 loss sufficiently induces mucinous cystic neoplasms and invasive pancreatic carcinoma in mice.

APC MUC4

8.55e-043444226411367
Pubmed

Diversification of stem cell molecular repertoire by alternative splicing.

MCAM WAC

9.06e-043544216183747
Pubmed

Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.

TNKS WAC CCSER1

9.33e-0415144317043677
Pubmed

A census of human transcription factors: function, expression and evolution.

CAMTA2 NKX6-1 SALL1 KLF4 ZFP36L1 NFE2L1

9.43e-0490844619274049
Pubmed

The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.

ANKRD11 KDM6B BAZ2B

1.04e-0315744330186101
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

ANKRD11 SALL1 UBN1 BAZ2B WAC ARID3B

1.22e-0395444636373674
Pubmed

A protein interaction network for pluripotency of embryonic stem cells.

SALL1 ARID3B

1.24e-034144217093407
InteractionSELE interactions

MTMR1 DIP2B DIP2A

1.67e-0523443int:SELE
Cytoband16p13.3

UBN1 PDPK1 SEC14L5

1.67e-0324444316p13.3
GeneFamilyCD molecules|Mucins

MUC16 MUC12 MUC4

4.34e-0621283648
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

APC CEP192 UBN1

2.69e-03181283694
CoexpressionBUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP

CAMTA2 ULK1 KDM6B PER2 KLF4 BAZ2B WAC MAP3K2 ARID3B

7.43e-06822449M6782
CoexpressionGSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP

APC DIP2B HERPUD2 BAZ2B MAP3K2

1.81e-05194445M7313
CoexpressionGSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP

MTMR1 IRS1 KDM6B BAZ2B ROR1

2.05e-05199445M9420
CoexpressionGSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_UP

ANKRD11 KDM6B PER2 CTTNBP2NL MAP3K2

2.05e-05199445M7142
CoexpressionAtlasFacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500

IRS1 NRXN3 SALL1 ZFP36L1 MUC4 SPRED3 ARID3B

4.77e-05495427Facebase_RNAseq_e10.5_Olfactory Pit_500
CoexpressionAtlasfacebase_RNAseq_e10.5_OlfacPit_2500_K0

DOCK3 APC NCKAP5 IRS1 SALL1 BAZ2B SPRED3 ARID3B CCSER1

6.68e-05926429facebase_RNAseq_e10.5_OlfacPit_2500_K0
CoexpressionAtlasfacebase_RNAseq_e10.5_OlfacPit_2500

DOCK3 APC NCKAP5 IRS1 NRXN3 SALL1 BAZ2B MICAL2 SPRED3 ARID3B CCSER1

8.79e-0514534211facebase_RNAseq_e10.5_OlfacPit_2500
CoexpressionAtlasFacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000

IRS1 NRXN3 SALL1 KLF4 ZFP36L1 MUC4 SPRED3 ARID3B CCSER1

1.06e-04984429Facebase_RNAseq_e10.5_Olfactory Pit_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500

APC TNKS SALL1 COL17A1 CTTNBP2NL ROR1

1.40e-04407426gudmap_developingLowerUrinaryTract_e14.5_ urethra_500
ToppCellControl|World / group, cell type (main and fine annotations)

NCKAP5 ZNF385B NRXN3 PER2 MICAL2 CCSER1

1.56e-08168446a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 ULK1 PER2 MUC4 BAZ2B

9.03e-071794456e965e424eebef50f0202cff75f458be395cfca1
ToppCellCOVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations)

NCKAP5 ZNF385B MICAL2 ROR1 CCSER1

9.03e-07179445a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCellCOVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type

FNIP2 DOCK3 NCKAP5 ROR1 CCSER1

9.80e-07182445287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCellfacs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HEG1 COL17A1 KDM6B ZFP36L1 MICAL2

1.24e-061914452f733d510a4862565a817f59829d8387d7ea26d9
ToppCellfacs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HEG1 COL17A1 KDM6B ZFP36L1 MICAL2

1.24e-061914458691eba35793e4e90f93d50c2145847ee51289f7
ToppCellCOVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type

FNIP2 DOCK3 NCKAP5 ROR1 CCSER1

1.31e-06193445dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCellEpithelial-club_cell|World / Lineage, Cell type, age group and donor

FNIP2 NCKAP5 NRXN3 MUC4 CCSER1

1.31e-061934452bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCellsevere-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

KDM6B KLF4 ZFP36L1 BAZ2B MICAL2

1.48e-06198445a77f3440d7fb6a50066abc7e9ad59e83798ef13d
ToppCellcontrol-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

FNIP2 NCKAP5 KLF4 CTTNBP2NL CCSER1

1.52e-0619944531825ba336603fe940dea6022e18ec25af110f4c
ToppCellcontrol-cDC|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

FNIP2 NCKAP5 KLF4 CTTNBP2NL CCSER1

1.56e-062004454a6d17a4225be38537d3dd8a39512051f597f4e0
ToppCellTransverse-Dendritic_cell|Transverse / Region, Cell class and subclass

FNIP2 NCKAP5 KLF4 CTTNBP2NL CCSER1

1.56e-06200445b0e9eaf0e57e53645e272e2cea9f09bfcfe12a9b
ToppCellTransverse-(5)_Dendritic_cell|Transverse / shred on region, Cell_type, and subtype

FNIP2 NCKAP5 KLF4 CTTNBP2NL CCSER1

1.56e-062004456c32a64f7c38818b93eec1e2d41067e5dbd90541
ToppCellSevere-B_naive-13|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)

NCKAP5 KDM6B MICAL2 CTTNBP2NL

5.26e-06116444f81a7c3e9cbf39124232d98e2a3a3e308137f391
ToppCellSevere-B_naive-13|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

NCKAP5 KDM6B MICAL2 CTTNBP2NL

6.02e-06120444d08edc09de8497714af55a6ca08a447cd71095e7
ToppCellAT1-AT2_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id

NCKAP5 CEP192 HEG1 NRXN3

1.27e-05145444cd5de30fd948024e3ad043c9411ce9f2722178b2
ToppCellfacs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FNIP2 CAMTA2 NRXN3 SALL1

1.38e-05148444ba277c898678dd36f8dc1d681301c71901b89055
ToppCellfacs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FNIP2 CAMTA2 NRXN3 SALL1

1.38e-05148444b4632029ebd14969bda59a1bd1454eadb8efe563
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

FNIP2 NCKAP5 CTTNBP2NL CCSER1

1.61e-051544445967a0a33456d5930fc492a700ebb015ac050abb
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

FNIP2 NCKAP5 CTTNBP2NL CCSER1

1.65e-051554449a27558c457f05808af07190b7a5006b047f1d58
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

FNIP2 NCKAP5 CTTNBP2NL CCSER1

1.65e-05155444ab539c04f10276ae919d82b1c75f99a84eb695bf
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

FNIP2 NCKAP5 CTTNBP2NL CCSER1

1.65e-05155444fab281db4c275d51240b122be78713c839ba5a95
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 PER2 ZFP36L1 MUC4

1.83e-0515944460b1f4dce2ce0911160fda17f137c064da31e2eb
ToppCellPBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

FNIP2 NCKAP5 CTTNBP2NL CCSER1

2.01e-05163444a09449a502627aa369db600dba5bda93de7ce5c0
ToppCellPBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

FNIP2 NCKAP5 CTTNBP2NL CCSER1

2.06e-05164444ed888b55d9c685096fd785878fcb264f4fee88d6
ToppCellFetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

NRXN3 COL17A1 PER2 CCSER1

2.27e-051684446521bead9789d626b86cbd08692c621c5a5aef33
ToppCellFetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

NRXN3 COL17A1 PER2 CCSER1

2.32e-05169444c3ee781735a9288ce1822b230d39bb91c1415589
ToppCellfacs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NCKAP5 HEG1 NRXN3 SALL1

2.48e-05172444f2c17c49b375b28ad47dc6cabda62f1c238023dd
ToppCellfacs-Heart-LV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NCKAP5 HEG1 NRXN3 SALL1

2.48e-051724446ab4f01098dddb789df298ddf97b3c384405ee6c
ToppCellLeuk-UTI-Myeloid-cDC1|Leuk-UTI / Disease, Lineage and Cell Type

FNIP2 NCKAP5 CTTNBP2NL CCSER1

2.54e-05173444226bb8d881f32d65c60f5e4c034c6d465f8e7ba5
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MCAM TKTL1 NKX6-1 ROR1

2.54e-051734442acd0693a2dfe04e3c1b2125ea63efe92d13150b
ToppCellBac-SEP-Myeloid-cDC1|Bac-SEP / Disease, Lineage and Cell Type

FNIP2 NCKAP5 ROR1 CCSER1

2.54e-05173444f88269327441858ddb8c49b9dd619b76fd53b1da
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MCAM TKTL1 NKX6-1 ROR1

2.54e-051734442415b6ff49f334da570577d4e93484d024a3dbd5
ToppCellLPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ZNF385B NRXN3 BAZ2B ROR1

2.78e-05177444b7fee75de7e96924af488a5baa2334711889ae7c
ToppCellAT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id

NCKAP5 ZFP36L1 MICAL2 ROR1

2.78e-051774443128b8d04687acee1ac4190b2569d6328b98eaf3
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

FNIP2 NCKAP5 CTTNBP2NL CCSER1

2.78e-05177444e68ad19963a3d8917dfdb81127a41c4fcbe61dd5
ToppCellICU-NoSEP-Myeloid-cDC1|ICU-NoSEP / Disease, Lineage and Cell Type

NCKAP5 CTTNBP2NL ROR1 CCSER1

2.78e-0517744433cd2c183ee8b597012efcbcae72131ac6beaf4e
ToppCellnormal_Pleural_Fluid-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass

FNIP2 NCKAP5 ROR1 CCSER1

2.97e-05180444a0b35067b6f2dbd8145da8bab760e9f650f045b0
ToppCellChildren_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

NCKAP5 NRXN3 MUC4 CCSER1

2.97e-05180444b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCellHealthy-multiplets|World / disease group, cell group and cell class

FNIP2 NCKAP5 CTTNBP2NL CCSER1

3.03e-05181444f8dbac3cd500cc8d80853312b00d124c27b8fd85
ToppCellControl-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations)

FNIP2 ZNF385B MUC4 CCSER1

3.03e-05181444c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCellCOVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type

NCKAP5 ZNF385B MICAL2 ROR1

3.17e-051834447b1a385ed54f93bfe85bf0c162e42d05d516b45c
ToppCellCOVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations)

NCKAP5 ZNF385B ZFP36L1 ROR1

3.17e-05183444dc1d380bf7564f290256cb7108063d1bd2da732b
ToppCellControl-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations)

MUC16 COL17A1 MUC4 CCSER1

3.17e-0518344415d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2
ToppCellEpithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor

MUC16 NRXN3 MUC4 CCSER1

3.17e-05183444940cbe298e9c53b5622af09264586ed823d3141f
ToppCell3'_v3-Lung-Myeloid_Dendritic-DC1|Lung / Manually curated celltypes from each tissue

FNIP2 NCKAP5 ROR1 CCSER1

3.17e-05183444e4cbd39575b5a4612d9934532e3bad63286f8aa5
ToppCellnormal-na-Myeloid-conventional_dendritic_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

NCKAP5 KLF4 CTTNBP2NL CCSER1

3.30e-0518544467e881a89a491665b8c612fff084c202c0c79235
ToppCell10x5'-Liver-Myeloid_Dendritic-DC1|Liver / Manually curated celltypes from each tissue

FNIP2 NCKAP5 CTTNBP2NL CCSER1

3.37e-05186444e823529ffd06352c6bdec102f221fdf27f7c7369
ToppCellAdult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor

NCKAP5 NRXN3 MUC4 CCSER1

3.44e-05187444ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCellControl-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class

NCKAP5 HEG1 ROR1 CCSER1

3.44e-051874443a032432f780525f4f4c2a358897d9989b1ecae7
ToppCellLA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper

NCKAP5 ZNF385B ROR1 CCSER1

3.52e-051884446d249fe92d51a19da19ec14bb2262d394255d577
ToppCell3'_v3-blood-Myeloid_Dendritic-DC1|blood / Manually curated celltypes from each tissue

NCKAP5 CTTNBP2NL ROR1 CCSER1

3.52e-05188444411d4dd5c9dee7ebd8db352640cf009e7b033ba9
ToppCelldroplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANKRD11 KDM6B ZFP36L1 WAC

3.52e-05188444d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCellCOVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations)

ZNF385B MUC4 MICAL2 CCSER1

3.52e-05188444c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCellfacs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DIP2B SALL1 ZFP36L1 CTTNBP2NL

3.59e-051894446dd4ec5ce4beb856f0d2d1654e3c4676d1d63736
ToppCellfacs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DIP2B SALL1 ZFP36L1 CTTNBP2NL

3.59e-051894443ae479ec7e00c57127cbe51a398329b10ca9848c
ToppCellRV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper

DOCK3 NCKAP5 ROR1 CCSER1

3.59e-051894449c1debd65c13d63fd4f3158917d621b44b714c26
ToppCellfacs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DIP2B SALL1 ZFP36L1 CTTNBP2NL

3.59e-05189444875df61ee48baa5142ba4d2427bdec1c53e5a828
ToppCellRV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper

FNIP2 NCKAP5 ROR1 CCSER1

3.59e-051894440a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCellfacs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DIP2B SALL1 ZFP36L1 CTTNBP2NL

3.59e-0518944497ef5215d841ff366a3e3682cd9bd04100cbfde0
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

NCKAP5 HEG1 MICAL2 ROR1

3.67e-0519044430b50d183d7649146eb1e79b47ba897355f1998a
ToppCellRV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper

FNIP2 NCKAP5 ROR1 CCSER1

3.67e-0519044493c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

SERTAD4 NCKAP5 NKX6-1 ZFP36L1

3.67e-051904447986586b7c82e91c71102cc8c4d7a689ae63ab4d
ToppCellCOVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations)

MUC16 NRXN3 MUC4 CCSER1

3.67e-0519044451ca9ef4df3220487152fcf684147730637c7cc1
ToppCellLV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper

DOCK3 NCKAP5 ROR1 CCSER1

3.82e-05192444ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCellrenal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD11 DIP2B NCKAP5 CCSER1

3.82e-05192444e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCellPND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MCAM HEG1 NRXN3 KLF4

3.82e-05192444cd4c9b9ab17a779c154264f7459020f51e528ba5
ToppCellVE-mDC1|VE / Condition, Cell_class and T cell subcluster

FNIP2 NCKAP5 CTTNBP2NL CCSER1

3.90e-0519344412b2708db9db8b88365b8ebeb4908f28c50081bb
ToppCellVE-mDC1-|VE / Condition, Cell_class and T cell subcluster

FNIP2 NCKAP5 CTTNBP2NL CCSER1

3.90e-051934445df6033bc0e4f96a20d526486a8e89c990e21831
ToppCellClub_cells|World / lung cells shred on cell class, cell subclass, sample id

SERTAD4 MUC16 ZFP36L1 MUC4

3.90e-051934449d3165dc5763a07a7d873f497624d9d6528fa2db
ToppCellBAL-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

FNIP2 KDM6B ZFP36L1 CCSER1

3.90e-05193444704378de39e1b6f108ab5b0ecbd594d414ec8ae4
ToppCellClub_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

SERTAD4 MUC16 ZFP36L1 MUC4

3.90e-051934446582c0367052b9d10fb629c383ee0c55872afd2d
ToppCellPND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MCAM HEG1 NRXN3 KLF4

3.90e-0519344458c590dd6f21bc7ae58ae1729dd574c0f1069592
ToppCellLPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NCKAP5 HEG1 BAZ2B CCSER1

3.98e-051944440b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCellRA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper

NCKAP5 ZNF385B ROR1 CCSER1

3.98e-0519444489812fb164065041357bb37a3c2d87028ec3de4e
ToppCellPBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

FNIP2 NCKAP5 CTTNBP2NL CCSER1

3.98e-05194444b16ed97eb6b7b7a220e943474c0d85c141b6e3a5
ToppCellPBMC-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NCKAP5 KLF4 CTTNBP2NL CCSER1

3.98e-051944445c60670ec24470225fabaa6071fdb4ef6e579840
ToppCellPBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

FNIP2 NCKAP5 CTTNBP2NL CCSER1

3.98e-051944442210f0755882d8f04edb4c109fb17c3f9149f6f7
ToppCellPBMC-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

NCKAP5 KLF4 CTTNBP2NL CCSER1

3.98e-051944446af2971d83f5ad6aed16d0ceb8bfc52f3947bc10
ToppCellRA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper

NCKAP5 ZNF385B ROR1 CCSER1

3.98e-05194444c3535f7cc0076653c72db582047cff053c322397
ToppCellPND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MCAM NCKAP5 HEG1 KLF4

3.98e-051944442c78e754cac848fd47172f94e392749eb0ab50d4
ToppCellBAL-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

FNIP2 KDM6B ZFP36L1 CCSER1

3.98e-0519444436f8ae4f2b3bf802f6ff0e9fc79e7f170f96ae8b
ToppCellPND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MCAM NCKAP5 HEG1 KLF4

3.98e-051944441b382508453c5b08fb617f626b230adf3b6cff99
ToppCellnucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NCKAP5 ZNF385B MICAL2 ROR1

3.98e-0519444453f3e49e91b1096f3226010e2de767efb490dfe4
ToppCellPND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MCAM NCKAP5 HEG1 KLF4

3.98e-0519444492a8e6e3e3f6fd9dacb723b58e7a8b63473e403e
ToppCellCOVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type

DOCK3 NCKAP5 ROR1 CCSER1

4.06e-05195444f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCellControl-Myeloid-cDC1|Control / Disease, Lineage and Cell Type

FNIP2 NCKAP5 CTTNBP2NL CCSER1

4.06e-0519544435b2fe0588877d30cbd5d3ae259fcfd959907429
ToppCellnucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NCKAP5 ZNF385B MICAL2 ROR1

4.06e-051954449406866f99555198a9be311fbd65751b70f35446
ToppCellPND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MCAM NCKAP5 HEG1 KLF4

4.06e-05195444cd011433b3b9bfb1adb13eca2f3f2a5db024cd94
ToppCellCOVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type

DOCK3 NCKAP5 ROR1 CCSER1

4.06e-0519544475fc81bddb246dca3b437fb60827b1d4fe416405
ToppCellPBMC-Control-Myeloid-cDC-cDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NCKAP5 KLF4 CTTNBP2NL CCSER1

4.14e-05196444553c22c7d48f3b4f6f2b2f10d6e668c5ebb09e8c
ToppCellPBMC-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

NCKAP5 KLF4 CTTNBP2NL CCSER1

4.14e-05196444e1f763fa9c11bf5f4d80e79f70f9485724ac23fe
ToppCellMid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF385B NRXN3 MICAL2 CCSER1

4.14e-05196444676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCellPBMC-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NCKAP5 KLF4 CTTNBP2NL CCSER1

4.14e-05196444d376168e15ec1cf618723259966c76be3698b9b0
ToppCellEnterocyte-C_05|Enterocyte / shred on cell type and cluster

MUC12 COL17A1 KLF4 MUC4

4.14e-05196444c307e5a70186567c62da938caa21749dc0e929d0
ToppCellControl-Myeloid-cDC|Control / Disease group, lineage and cell class

NCKAP5 KLF4 CTTNBP2NL CCSER1

4.14e-0519644485d92bc226cc28384c30991cc4ebb02ec2e3ec99
ToppCellPBMC-Control-Myeloid-cDC-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

NCKAP5 KLF4 CTTNBP2NL CCSER1

4.14e-051964444a9095ba3f6709f88f32bf09184553f4bd211f43
ToppCellhealthy_donor-Myeloid-Dendritic-cDC|healthy_donor / Disease condition, Lineage, Cell class and subclass

NCKAP5 KLF4 CTTNBP2NL CCSER1

4.14e-05196444aac79fc45cab4a16e2fa02652ece0999591261a5
ToppCellhealthy_donor-Myeloid-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass

NCKAP5 KLF4 CTTNBP2NL CCSER1

4.14e-05196444ea590b8ea3d13ff93cb5863a44936b0cfdf3b868
ToppCellnormal-na-Myeloid-conventional_dendritic_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex

NCKAP5 KLF4 CTTNBP2NL CCSER1

4.22e-0519744417c6d2a7baef6393c3e2d3e65cc924df22049eb0
Drug1-methylanthracene

FNIP2 ANKRD11 UBN1 PER2 KLF4 ZFP36L1 CTTNBP2NL MAP3K2 CCSER1

4.81e-06677449ctd:C051246
Drugpivalic anhydride

HEG1 SALL1

1.09e-053442CID000015234
Drugmanganese tetroxide

MCAM DOCK3 SALL1

1.32e-0524443CID000014825
Drugfluoranthene

FNIP2 ANKRD11 UBN1 PER2 KLF4 ZFP36L1 CTTNBP2NL MAP3K2 CCSER1

2.98e-05851449ctd:C007738
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

APC MTMR1 UBN1 KLF4 MICAL2

3.28e-051914451059_DN
DrugTolazamide [1156-19-0]; Up 200; 12.8uM; PC3; HT_HG-U133A

MTMR1 HEG1 PER2 KLF4 ZFP36L1

3.62e-051954454003_UP
DrugTetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; PC3; HT_HG-U133A

NRXN3 COL17A1 PER2 KLF4 ZFP36L1

3.99e-051994455728_UP
Diseasemultiple myeloma

ANKRD11 TNKS WAC CCSER1

2.17e-05112434EFO_0001378
DiseaseCongenital Abnormality

SALL1 KLF4

1.13e-0411432C0000768
Diseasepolychlorinated biphenyls measurement, gestational serum measurement

NCKAP5 CCSER1

1.36e-0412432EFO_0007042, EFO_0007964
DiseaseN-acetylmethionine measurement

DOCK3 MICAL2

2.15e-0415432EFO_0021427
DiseaseAutism Spectrum Disorders

ANKRD11 DIP2A NRXN3

2.62e-0485433C1510586
DiseaseLipidemias

APC IRS1

2.78e-0417432C1706412
DiseaseHyperlipidemia

APC IRS1

2.78e-0417432C0020473
Diseasefacial asymmetry measurement

NRXN3 ROR1

3.49e-0419432EFO_0009751
Diseasemean platelet volume

ANKRD11 MTMR1 IRS1 UBN1 ZFP36L1 NFE2L1 SEC14L5

6.27e-041020437EFO_0004584
Diseaseimmature platelet measurement

DOCK3 ZFP36L1 SEC14L5

7.02e-04119433EFO_0803541
Diseaseage at first birth measurement

FNIP2 DOCK3 TNKS

7.19e-04120433EFO_0009101
Diseasemelanoma

ANKRD11 DOCK3 NKX6-1

8.28e-04126433EFO_0000756
DiseaseOvarian Mucinous Adenocarcinoma

ULK1 ROR1

9.39e-0431432C1335167
Diseasesexual dimorphism measurement

ANKRD11 DOCK3 APC DIP2B TNKS NRXN3 UBN1

1.01e-031106437EFO_0021796
Diseasechildhood trauma measurement, smoking behaviour measurement

NRXN3 CCSER1

1.97e-0345432EFO_0005671, EFO_0007979
Diseasefibrinogen measurement, tissue plasminogen activator measurement

DIP2B ZFP36L1

1.97e-0345432EFO_0004623, EFO_0004791
Diseasefibrinogen measurement, plasminogen activator inhibitor 1 measurement

DIP2B ZFP36L1

1.97e-0345432EFO_0004623, EFO_0004792
Diseasehepatocellular carcinoma (implicated_via_orthology)

APC NFE2L1

2.34e-0349432DOID:684 (implicated_via_orthology)
DiseaseIschemic stroke, fibrinogen measurement

DIP2B ZFP36L1

2.93e-0355432EFO_0004623, HP_0002140
Diseasefactor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement

DIP2B ZFP36L1

3.04e-0356432EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791
Diseasefibrinogen measurement, factor VII measurement

DIP2B ZFP36L1

3.26e-0358432EFO_0004619, EFO_0004623
Diseasecholangiocarcinoma (is_marker_for)

MUC16 MUC4

3.95e-0364432DOID:4947 (is_marker_for)
Diseasesusceptibility to cold sores measurement

MUC16 MICAL2

4.07e-0365432EFO_0008402

Protein segments in the cluster

PeptideGeneStartEntry
SASSSSSSHCSPSPT

ARID3B

531

Q8IVW6
ASHSRGSSSSSHSSS

COL17A1

1286

Q9UMD9
LSSSGSSLSPSSTAS

CTTNBP2NL

406

Q9P2B4
SSLSASSTSSHGSSA

ANKRD11

516

Q6UB99
SSSTLTSSPHSGTSK

BAZ2B

721

Q9UIF8
AHTSPSSSSSSSSSG

CAMTA2

286

O94983
SSPSSSNTVGVHSSS

CCSER1

31

Q9C0I3
VHSSSPSSTNSSSGS

CCSER1

41

Q9C0I3
SSSERGSSPSHSATS

MTMR1

646

Q13613
SPSSLSSSEGSSSSS

NFE2L1

486

Q14494
EPGTSSTSNLSSTSH

MUC16

8316

Q8WXI7
VTSSSSASSGHTTPL

MUC4

2371

Q99102
SSASASSSSSPSSSG

KLF4

126

O43474
TSSSNSNSGSHSSSP

KDM6B

551

O15054
ASPSGAGSSDTSHTS

PER2

1086

O15055
FSPTDHSLSTSSGSS

MAP3K2

301

Q9Y2U5
GSSTSSSASSTLSHG

DIP2B

181

Q9P265
SSSSSSSSSSSSGPP

HEG1

661

Q9ULI3
ATSPVSLSSSSTSGH

IRS1

386

P35568
SLSSSSTSGHGSTSD

IRS1

391

P35568
SQASPSSSSLSSTHS

DOCK3

1736

Q8IZD9
SSSSSISSHSSSGGS

FNIP2

101

Q9P278
LSHSSPSEISGTSSS

CEP192

991

Q8TEP8
SNSSSDHSGSTTPSS

HERPUD2

111

Q9BSE4
TSSSASSTSSHPGGR

DIP2A

176

Q14689
LSAATSSSSSGQSHS

SEC14L5

676

O43304
SSSSSGQSHSSSLVS

SEC14L5

681

O43304
SGSHSSTAPSSSSSS

SALL1

141

Q9NSC2
PSSSSHSSSPPSSSS

MICAL2

1276

O94851
HSSSPPSSSSTSVSG

MICAL2

1281

O94851
SNTTTGLSTSTASPH

MCAM

526

P43121
SSSSSSSSPAKSHNS

NCKAP5

1116

O14513
PSASPSGSSSSSSSS

NKX6-1

116

P78426
SSSSTSSSPGSHSQH

NRXN3

41

Q9HDB5
SSSSHSLSASDTGLP

PDPK1

391

O15530
SHSCTTPSTSSASGL

WAC

316

Q9BTA9
SASSSSSSSSSSPPL

SERTAD4

221

Q9NUC0
SHYSGPSLPSSTSSS

RIG

11

Q13278
PFSSSSSSKHSSPSG

APC

2761

P25054
PSSASGSTSTGHVTS

ROR1

856

Q01973
LSSSSSSHSGSDSPT

ZFP36L1

306

Q07352
GSLTPSSSSSSSSPS

SPRED3

116

Q2MJR0
TSSSSSSPSSPGSSL

TNKS

136

O95271
PSSSSSSSSPSSSHS

TPRXL

56

Q17RH7
SSSSPSSSHSSSSPS

TPRXL

61

Q17RH7
SSSHSSSSPSSSHSS

TPRXL

66

Q17RH7
SSSPSSSHSSSSPSS

TPRXL

71

Q17RH7
SSHSSSSPSSSSSTS

TPRXL

76

Q17RH7
ASPSSNSSTGSTCHT

ZNF385B

76

Q569K4
SASSSSSHKTPASSS

UBN1

866

Q9NPG3
STSSGHPTSCSSSSE

TKTL1

41

P51854
GSSSSSSSTSHLASP

ULK1

301

O75385
PSQESTTSHSSSGST

MUC12

1046

Q9UKN1
TTSHSSSGSTDTALS

MUC12

1051

Q9UKN1
GSPSSTPTTHFSASS

MUC12

1861

Q9UKN1
ASGTTPSSAHSTTSG

MUC12

2281

Q9UKN1
SGTTPSSAHSTTSGR

MUC12

2756

Q9UKN1
TTSHSSSGSTDTALS

MUC12

3691

Q9UKN1
GSPSSTPTTHFSASS

MUC12

4501

Q9UKN1